Benefits of Vitamin A 2025
Vitamin A stands as one of the most crucial fat-soluble vitamins essential for maintaining optimal health across all age groups in the United States. This powerful micronutrient plays a fundamental role in vision health, immune system function, cellular differentiation, and reproductive health. As we navigate through 2025, understanding the importance of vitamin A becomes increasingly vital as research continues to reveal its profound impact on preventing chronic diseases and maintaining overall wellness. The nutrient exists in two primary forms: preformed vitamin A (retinol) found in animal products, and provitamin A carotenoids (such as beta-carotene) present in plant-based foods, both converting to active forms the body can utilize.
The significance of vitamin A extends far beyond basic nutrition. According to the latest data from the National Institutes of Health Office of Dietary Supplements, this essential vitamin regulates gene expression, supports the integrity of epithelial tissues throughout the body, and serves as a critical component in the visual cycle that enables us to see in low-light conditions. Vitamin A deficiency remains rare in the United States, yet ensuring adequate intake remains a public health priority, particularly for vulnerable populations including pregnant women, young children, and individuals with malabsorption disorders. The vitamin’s role in immune function has gained renewed attention, with research demonstrating its capacity to enhance barrier function, strengthen innate immunity, and support the body’s defense mechanisms against infections.
Interesting Vitamin A Facts & Latest Statistics in the US 2025
| Vitamin A Fact Category | 2025 Data | Key Detail |
|---|---|---|
| Population with Inadequate Intake | 45% of US adults | Fall below the Estimated Average Requirement |
| Deficiency Rate in US | Less than 1% | Based on serum retinol concentrations |
| Adult Male RDA | 900 mcg RAE/day | Retinol Activity Equivalents |
| Adult Female RDA | 700 mcg RAE/day | Standard recommendation for women |
| Pregnant Women RDA | 770 mcg RAE/day | Ages 19-50 years |
| Lactating Women RDA | 1,300 mcg RAE/day | Higher needs during breastfeeding |
| Tolerable Upper Intake Level | 3,000 mcg RAE/day | For adults (preformed vitamin A only) |
| Supplement Usage Adults | 75% in 2024 | Up from 57.6% in 2018 |
| Vitamin Toxicity Cases US | Over 50,000 in 2021 | Reported to poison control centers |
| Vitamin A Specific Toxicity | 400-500 calls/year | To US poison control centers |
| Mean Dietary Intake (Men) | Below 900 mcg RAE | Many adults not meeting RDA |
| Mean Dietary Intake (Women) | Below 700 mcg RAE | Indicating widespread inadequacy |
Data source: National Institutes of Health Office of Dietary Supplements (March 2025 update), National Health and Nutrition Examination Survey (NHANES 2005-2016), American Association of Poison Control Centers National Poison Data System (2021)
The data presented reveals a paradoxical situation in the United States regarding vitamin A nutrition. While overt vitamin A deficiency affecting less than 1% of the population remains remarkably rare, nearly 45% of US adults consume less than the Estimated Average Requirement, indicating widespread nutritional inadequacy. This discrepancy exists because the body efficiently stores vitamin A in the liver, and serum retinol levels remain stable even when dietary intake fluctuates. The Recommended Dietary Allowance (RDA) of 900 mcg RAE per day for men and 700 mcg RAE per day for women represents the intake level sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals. However, dietary surveys consistently show that many Americans fall short of these recommendations, with 51% of adults not meeting the EAR when accounting for fortified foods.
The surge in supplement usage from 57.6% in 2018 to 75% in 2024 reflects growing health consciousness, particularly following the COVID-19 pandemic. This dramatic increase underscores Americans’ proactive approach to preventive healthcare. However, this trend brings concerns about vitamin A toxicity, with over 50,000 instances of vitamin toxicity reported to US poison control centers in 2021, including 400-500 calls specifically related to vitamin A annually. The Tolerable Upper Intake Level of 3,000 mcg RAE per day for adults serves as a critical safety threshold, as excessive preformed vitamin A intake can lead to hypervitaminosis A, causing serious health complications including liver damage, bone abnormalities, and during pregnancy, severe birth defects.
Vitamin A Dietary Requirements by Age Group in the US 2025
| Age Group | Males (mcg RAE/day) | Females (mcg RAE/day) | Tolerable Upper Level (mcg RAE/day) |
|---|---|---|---|
| 0-6 months (AI) | 400 | 400 | 600 |
| 7-12 months (AI) | 500 | 500 | 600 |
| 1-3 years | 300 | 300 | 900 |
| 4-8 years | 400 | 400 | 900 |
| 9-13 years | 600 | 600 | 1,700 |
| 14-18 years | 900 | 700 | 2,800 |
| 19+ years | 900 | 700 | 3,000 |
| Pregnancy (14-18 years) | – | 750 | 2,800 |
| Pregnancy (19-50 years) | – | 770 | 3,000 |
| Lactation (14-18 years) | – | 1,200 | 2,800 |
| Lactation (19-50 years) | – | 1,300 | 3,000 |
Data source: National Institutes of Health Office of Dietary Supplements, Dietary Reference Intakes from the Food and Nutrition Board at the National Academies of Sciences, Engineering, and Medicine (2025)
The Recommended Dietary Allowances presented demonstrate how vitamin A requirements vary significantly across different life stages and physiological conditions. For infants aged 0-6 months, an Adequate Intake (AI) of 400 mcg RAE daily suffices, typically met through breast milk which contains approximately 485 mcg/L of vitamin A. Children’s needs progressively increase with growth, reaching 300 mcg RAE daily for toddlers aged 1-3 years and 600 mcg RAE for adolescents aged 9-13 years. The distinction between males and females emerges at age 14, when males require 900 mcg RAE compared to 700 mcg RAE for females, reflecting differences in body composition and metabolic demands.
Pregnancy and lactation dramatically increase vitamin A requirements. Pregnant women aged 19-50 years need 770 mcg RAE daily, representing a modest increase from non-pregnant requirements to support fetal development. However, lactating women require significantly more at 1,300 mcg RAE per day, nearly double the standard female RDA, to ensure adequate vitamin A transfers to breast milk for infant nutrition. The Tolerable Upper Intake Levels provide crucial safety boundaries, with adults capped at 3,000 mcg RAE daily to prevent hypervitaminosis A. Notably, children exhibit greater sensitivity to vitamin A toxicity, with lower upper limits ranging from 600 mcg RAE for infants to 2,800 mcg RAE for adolescents. These carefully established guidelines reflect decades of nutritional research aimed at optimizing health while preventing both deficiency and toxicity.
Vitamin A Intake Inadequacy Among US Population Groups in the US 2025
| Nutrient | Percentage of US Population Below EAR | Population Impact |
|---|---|---|
| Vitamin A | 45% | Moderate inadequacy |
| Vitamin C | 46% | Moderate inadequacy |
| Vitamin D | 95% | Severe inadequacy |
| Vitamin E | 84% | High inadequacy |
| Zinc | 15% | Low inadequacy |
| Vitamin A (Children 2-18) | Less than 6% | Most meet requirements |
| Vitamin A (Adults) | 51% | Fall short of EAR |
Data source: National Health and Nutrition Examination Survey (NHANES 2005-2016), Linus Pauling Institute Micronutrient Inadequacies Overview (August 2025)
The comprehensive analysis of micronutrient inadequacies reveals that 45% of the US adult population consumes less than the Estimated Average Requirement for vitamin A, positioning it among the nutrients of moderate concern alongside vitamin C at 46%. This widespread inadequacy, while not resulting in clinical deficiency symptoms in most individuals, raises important questions about long-term health implications. The body’s remarkable ability to store vitamin A in hepatic stellate cells means that serum retinol concentrations remain stable even when dietary intake proves suboptimal, explaining why less than 1% of Americans exhibit frank deficiency despite nearly half consuming inadequate amounts.
The contrast between children and adults proves particularly striking. More than 94% of children and adolescents aged 2-18 years meet or exceed their vitamin A requirements, largely due to fortification programs in milk and breakfast cereals, along with mandatory school nutrition standards. Fortified ready-to-eat cereals and fortified milk serve as primary vitamin A sources for this demographic. However, 51% of adults fall short even when accounting for fortified foods, suggesting that dietary patterns shift unfavorably with age. This inadequacy becomes especially concerning given vitamin A’s critical roles in immune function, with research demonstrating that 45% of the population with inadequate intake may experience compromised immune responses. The data underscores the need for targeted nutrition education and potential expansion of fortification programs to address this silent but widespread nutritional gap affecting nearly half of American adults.
Top Food Sources of Vitamin A in the US 2025
| Food Source | Vitamin A Content (mcg RAE per serving) | Percentage of Daily Value | Form of Vitamin A |
|---|---|---|---|
| Beef Liver (3 oz, cooked) | 6,582 | 731% | Preformed (Retinol) |
| Sweet Potato (1 cup, baked) | 1,403 | 156% | Provitamin A (Beta-carotene) |
| Spinach (1 cup, cooked) | 943 | 105% | Provitamin A (Beta-carotene) |
| Carrots (1 cup, raw) | 918 | 102% | Provitamin A (Beta-carotene) |
| Pumpkin (1 cup, canned) | 953 | 106% | Provitamin A (Beta-carotene) |
| Cantaloupe (1 cup, cubed) | 270 | 30% | Provitamin A (Beta-carotene) |
| Red Bell Pepper (1 cup, raw) | 187 | 21% | Provitamin A (Beta-carotene) |
| Mango (1 cup, sliced) | 89 | 10% | Provitamin A (Beta-carotene) |
| Fortified Milk (1 cup) | 149 | 17% | Preformed (Retinol) |
| Fortified Breakfast Cereal (1 serving) | 127-149 | 14-17% | Preformed (Retinol) |
| Egg (1 large) | 80 | 9% | Preformed (Retinol) |
| Cod Liver Oil (1 tsp) | 1,350 | 150% | Preformed (Retinol) |
Data source: USDA FoodData Central, National Institutes of Health Office of Dietary Supplements (2025)
The diversity of vitamin A food sources enables Americans to meet their nutritional requirements through varied dietary patterns. Beef liver stands as the most concentrated source, delivering an astounding 6,582 mcg RAE per 3-ounce serving—731% of the daily value—though its high cholesterol content necessitates moderation. Plant-based sources rich in beta-carotene offer safer alternatives for meeting needs without toxicity risk. A single cup of baked sweet potato provides 1,403 mcg RAE (156% DV), while cooked spinach delivers 943 mcg RAE (105% DV), demonstrating that colorful vegetables serve as nutritional powerhouses. The vibrant orange hue of carrots, providing 918 mcg RAE per cup (102% DV), directly correlates with their beta-carotene content, the most abundant provitamin A carotenoid.
Food fortification programs significantly contribute to vitamin A intake in the United States. Federal regulations mandate vitamin A fortification in margarine, and voluntary fortification occurs in milk, breakfast cereals, and other processed foods. One cup of fortified milk delivers 149 mcg RAE (17% DV), while fortified breakfast cereals provide 127-149 mcg RAE per serving (14-17% DV). These fortification efforts prove particularly effective for children, explaining why 94% meet their vitamin A requirements. For adults seeking to optimize intake, incorporating a mix of animal sources like eggs (80 mcg RAE or 9% DV) and plant sources ensures both immediate vitamin A availability and safe long-term consumption. The conversion efficiency differs between sources: the body converts 12 mcg of dietary beta-carotene into 1 mcg of retinol, whereas preformed vitamin A from animal products requires no conversion, providing immediate biological activity.
Vitamin A Deficiency vs Toxicity in the US 2025
| Condition | Prevalence/Incidence in US | Primary Cause | Key Symptoms |
|---|---|---|---|
| Vitamin A Deficiency | Less than 1% of population | Rare in developed countries | Night blindness, dry eyes, infections |
| Subclinical Deficiency (Adults) | 45-51% below EAR | Inadequate dietary intake | No immediate symptoms |
| At-Risk Groups | IBD, post-bariatric surgery patients | Malabsorption conditions | Variable symptoms |
| Acute Vitamin A Toxicity | 400-500 cases/year | High-dose supplements | Headache, nausea, dizziness |
| Chronic Vitamin A Toxicity | Estimated 60,000 cases/year | Long-term supplement overuse | Liver damage, bone pain, skin changes |
| Pregnancy-Related Toxicity Risk | Variable | Excess supplement intake | Birth defects, fetal abnormalities |
| Children Sensitivity | Higher risk | Lower tolerance threshold | Growth problems, bone abnormalities |
Data source: StatPearls Publishing (2025), National Health and Nutrition Examination Survey, American Association of Poison Control Centers (2021), US National Library of Medicine
The United States presents a unique epidemiological profile regarding vitamin A status. Clinical vitamin A deficiency affecting less than 1% of the population stands as a testament to food security, fortification programs, and dietary diversity. However, this low deficiency rate masks the reality that 45-51% of adults consume suboptimal amounts, creating a state of subclinical inadequacy that may compromise immune function and increase disease susceptibility over time. Certain populations face elevated deficiency risks, including individuals with inflammatory bowel disease (IBD), post-bariatric surgery patients, those with pancreatic insufficiency, and persons with chronic liver disease, as these conditions impair the absorption, storage, or conversion of vitamin A.
Conversely, vitamin A toxicity represents a growing concern in supplement-heavy American culture. Poison control centers receive 400-500 calls annually specifically about vitamin A, contributing to over 60,000 total cases of vitamin toxicity reported in 2021. The US National Library of Medicine documents approximately 60,000 cases of vitamin A toxicity annually, with supplements identified as the most common cause. Acute toxicity occurs after consuming 25,000 IU/kg body weight, manifesting within hours to days with severe headaches, blurred vision, nausea, and coordination problems. Chronic toxicity develops from consuming 4,000 IU/kg daily for 6-15 months, leading to more serious complications including hepatomegaly, portal hypertension, bone abnormalities, and potential liver failure requiring transplantation in severe cases. Pregnant women face particular risks, as excessive preformed vitamin A intake above 3,000 mcg RAE daily can cause teratogenic effects, resulting in birth defects affecting the baby’s eyes, skull, lungs, and heart.
Vitamin A Supplement Market in the US 2025
| Market Metric | 2025 Value | Growth Rate/Projection |
|---|---|---|
| US VMS Market Size | $41 billion | 5% growth from 2024 |
| Global Vitamin A Market | $628.2 million | Expected to reach $902.3M by 2032 |
| Online Vitamin Sales US | $25.6 billion | 3.0% growth in 2025 |
| Adult Supplement Usage | 75% in 2024 | Up from 57.6% in 2018 |
| North America Market Share | 35% | Dominant regional position |
| Retinol Segment Share | 55% | Of total vitamin A market |
| Food Application Share | 45.9% | Largest application segment |
| Personalization Interest | 52% | Consumers interested in AI-driven solutions |
| Transparency Demand | 31% | Want more ingredient information |
Data source: Coherent Market Insights (2025), IBISWorld Industry Analysis (2025), Mintel Market Intelligence (November 2025), Fortune Business Insights
The US vitamins, minerals, and supplements (VMS) market reached a remarkable $41 billion in 2025, representing 5% growth from 2024, with projections indicating continued expansion toward $53 billion in the near future. Within this broader landscape, the global vitamin A market specifically was valued at $628.2 million in 2025 and shows robust momentum with expectations to reach $902.3 million by 2032, demonstrating a 5.3% compound annual growth rate (CAGR). North America commands 35% of the global vitamin A market share, driven by robust healthcare infrastructure, widespread consumer health awareness, and established preventive healthcare practices among Americans.
The transformation of consumer behavior following the COVID-19 pandemic dramatically reshaped the supplements landscape. Adult supplement usage surged from 57.6% in 2018 to 75% by 2024, with the online vitamin and supplement sales sector reaching $25.6 billion through 1.8% CAGR growth over five years, including 3.0% growth anticipated for 2025. The retinol segment captures 55% of the vitamin A market share due to growing health consciousness and demand for nutritive foods, while food applications dominate with 45.9% market share, reflecting widespread fortification of dietary staples including milk, cereals, and processed foods. Emerging trends reveal that 52% of consumers express interest in AI-driven, personalized vitamin solutions, while 31% demand greater transparency about ingredient sourcing and formulation. The rise of direct-to-consumer brands emphasizing clean labels, traceability, and personalized nutrition continues reshaping market dynamics, challenging traditional supplement manufacturers to innovate beyond conventional one-size-fits-all approaches.
Vitamin A and Immune Function in the US 2025
| Immune Function Aspect | Vitamin A Role | Impact of Deficiency |
|---|---|---|
| Innate Immunity | Enhances barrier function | Compromised epithelial integrity |
| Phagocytic Activity | Supports macrophages/neutrophils | Reduced pathogen clearance |
| Antimicrobial Peptides | Regulates cathelicidin production | Decreased infection resistance |
| Adaptive Immunity | Modulates T-cell differentiation | Impaired immune response |
| Respiratory Protection | Maintains lung epithelium | Increased pneumonia risk |
| Measles Reduction | 50% reduction in new cases | Critical for child health |
| Population with Inadequacy | 45% below EAR | Potentially compromised immunity |
Data source: National Health and Nutrition Examination Survey (NHANES 2005-2016), National Institutes of Health Office of Dietary Supplements (2025), PMC Studies on Immune Health Nutrients
Vitamin A’s immunological significance extends far beyond basic nutrition, serving as a critical regulator of both innate and adaptive immune systems. The vitamin enhances barrier function of epithelial cells throughout the body, including the eyes, intestinal tract, and respiratory system, providing the first line of defense against pathogen entry. Research demonstrates that vitamin A enhances chemotactic, phagocytic, and bactericidal activities of monocytes, macrophages, and neutrophils—key innate immune cells responsible for neutralizing pathogens. The vitamin regulates production of antimicrobial proteins including cathelicidin and defensins, which protect the body by killing pathogens directly. In the respiratory tract, antimicrobial peptide expression helps shield lungs from infection, explaining why vitamin A deficiency correlates with increased susceptibility to respiratory diseases such as pneumonia.
The adaptive immune system equally depends on adequate vitamin A status. The vitamin influences T-cell differentiation, ensuring balanced immune responses capable of mounting specific defenses while avoiding excessive inflammation. Clinical evidence underscores these immune benefits: a Cochrane Review analyzing vitamin A supplementation in children demonstrated a 50% reduction in new measles cases, though supplementation did not affect mortality from measles. Given that 45% of the US population consumes less than the Estimated Average Requirement for vitamin A, this widespread inadequacy may translate to millions of Americans experiencing suboptimal immune function. While not causing overt immunodeficiency, subclinical inadequacy could increase susceptibility to respiratory infections, impair vaccine responses, and compromise the body’s ability to fight off common pathogens. This immunological dimension makes ensuring adequate vitamin A intake a matter of public health significance, particularly during seasonal flu periods and emerging infectious disease threats.
Vitamin A Forms and Bioavailability in the US 2025
| Vitamin A Form | Food Sources | Conversion Ratio to Retinol | Bioavailability |
|---|---|---|---|
| Retinol (Preformed) | Liver, dairy, eggs, fish | 1:1 (direct use) | 70-90% absorbed |
| Retinyl Palmitate | Fortified foods, supplements | 1:1 (direct use) | High absorption |
| Beta-Carotene (Supplement) | Vitamin capsules | 2:1 | Moderate absorption |
| Beta-Carotene (Food) | Carrots, sweet potatoes | 12:1 | Lower absorption |
| Alpha-Carotene | Orange vegetables | 24:1 | Lower absorption |
| Beta-Cryptoxanthin | Papaya, oranges | 24:1 | Lower absorption |
| With Fat Addition | Any provitamin A source | Improved conversion | Enhanced absorption |
Data source: National Institutes of Health Office of Dietary Supplements (March 2025), Food and Nutrition Board at National Academies
Understanding vitamin A bioavailability proves essential for optimizing nutritional status. The term Retinol Activity Equivalents (RAE) was established to account for different bioactivities of various vitamin A forms. Preformed vitamin A including retinol and retinyl esters from animal products offers immediate biological availability with 70-90% absorption efficiency and 1:1 conversion—meaning 1 mcg of retinol provides 1 mcg RAE. This direct utilization explains why liver, eggs, and fortified dairy products rapidly increase vitamin A status. Conversely, provitamin A carotenoids require enzymatic conversion in the intestinal mucosa and liver, with efficiency varying significantly by source and form.
The conversion disparities prove substantial: 2 mcg of supplemental beta-carotene converts to 1 mcg of retinol (2:1 ratio), while 12 mcg of dietary beta-carotene from food yields only 1 mcg of retinol (12:1 ratio). Other carotenoids prove even less efficient, with alpha-carotene and beta-cryptoxanthin requiring 24 mcg to produce 1 mcg retinol (24:1 ratio). These dramatic differences stem from variable absorption rates, conversion enzyme efficiency, and the matrix effect of food. Absorption of provitamin A carotenoids improves significantly when consumed with dietary fat, as these compounds are fat-soluble. Adding oil to salads, cooking orange vegetables with healthy fats, or consuming them alongside protein sources enhances conversion efficiency. This variability means vegetarians and vegans must consume substantially more beta-carotene-rich foods than omnivores consuming preformed vitamin A to meet requirements. Some individuals possess genetic variations affecting carotenoid conversion enzymes, making them “low responders” who convert plant sources less efficiently, potentially necessitating 200-300% more dietary carotenoids to achieve adequate status.
Vitamin A Toxicity Symptoms and Management in the US 2025
| Toxicity Type | Threshold Dose | Onset Time | Primary Symptoms |
|---|---|---|---|
| Acute Toxicity | 25,000 IU/kg single dose | Days to weeks | Severe headache, nausea, vomiting, dizziness |
| Chronic Toxicity | 4,000 IU/kg/day for 6-15 months | Months to years | Liver damage, bone pain, hair loss, skin changes |
| Pregnancy Toxicity | Above 3,000 mcg RAE/day | During gestation | Birth defects (eyes, skull, lungs, heart) |
| Children Sensitivity | 1,500 IU/kg/day | Variable | Growth problems, bone abnormalities |
| Liver Complications | Prolonged excess | Years | Hepatomegaly, fibrosis, cirrhosis |
| Bone Effects | Chronic intake above UL | Months to years | Osteoporosis, fractures, bone pain |
| Skin Manifestations | Variable excess | Weeks to months | Dry skin, pruritus, desquamation |
Data source: StatPearls Publishing (January 2025), National Institutes of Health (March 2025), American Association of Poison Control Centers
Vitamin A toxicity, medically termed hypervitaminosis A, occurs when excessive preformed vitamin A accumulates in body tissues, particularly the liver. Acute toxicity manifests after consuming 25,000 IU/kg body weight in a single dose or over a few days—equivalent to 100 times the RDA—producing severe headache, blurred vision, nausea, vomiting, dizziness, aching muscles, and coordination problems within hours to days. Children prove particularly vulnerable, with reports indicating toxicity from daily intakes of 1,500 IU/kg body weight. Chronic toxicity develops insidiously from consuming 4,000 IU/kg daily for 6-15 months, presenting with more serious complications including hepatomegaly, elevated liver enzymes progressing to fibrosis or cirrhosis, bone pain and fractures due to increased bone resorption, hair loss, dry skin with desquamation, and in severe cases, pseudotumor cerebri causing increased intracranial pressure.
Pregnancy represents a critical period where vitamin A toxicity poses severe teratogenic risks. Intake exceeding 3,000 mcg RAE daily (10,000 IU) during pregnancy can cause devastating birth defects affecting fetal development of eyes, skull, lungs, and heart. This concern extends to topical retinoid creams used for acne or anti-aging, though dermal absorption remains controversial. Management of hypervitaminosis A centers on immediate cessation of all vitamin A sources, whether dietary, supplemental, or pharmaceutical. Most patients experience gradual symptom resolution within weeks to months after discontinuation, with laboratory values normalizing as hepatic stores deplete. However, severe cases involving liver fibrosis or cirrhosis may prove irreversible, potentially requiring liver transplantation. Bone density loss may persist even after stopping excess intake. Prevention remains paramount: never exceed 3,000 mcg RAE daily from preformed vitamin A sources, avoid combining vitamin A supplements with retinoid medications like isotretinoin (Accutane), pregnant women should not take more than one prenatal vitamin daily, and individuals should have their total vitamin A intake assessed including fortified foods, multivitamins, and individual supplements. The 400-500 annual poison control calls regarding vitamin A underscore the ongoing need for public education about safe supplementation practices.
Vitamin A in Special Populations in the US 2025
| Special Population | Unique Considerations | Recommended Approach |
|---|---|---|
| Pregnant Women | Higher needs (770 mcg RAE/day) | Avoid excess preformed vitamin A |
| Lactating Women | Highest needs (1,300 mcg RAE/day) | Ensure adequate intake for milk production |
| Premature Infants | Born with low stores | May require supplementation under medical supervision |
| IBD Patients | Malabsorption issues | Monitor status, may need higher intake |
| Post-Bariatric Surgery | Bypassed duodenum | Lifelong supplementation often needed |
| Chronic Liver Disease | Impaired storage/mobilization | Complex management required |
| Vegans/Vegetarians | Only provitamin A sources | Must consume abundant plant sources |
| Elderly Adults | Decreased absorption | May need fortified foods or supplements |
Data source: StatPearls Publishing (2025), National Institutes of Health Office of Dietary Supplements (March 2025)
Special populations face unique challenges regarding vitamin A nutrition requiring tailored approaches. Pregnant women need 770 mcg RAE daily to support fetal development, particularly for visual system formation, immune system maturation, and organ development. However, they must scrupulously avoid exceeding 3,000 mcg RAE from preformed sources, as excessive intake causes teratogenic effects. Prenatal vitamins provide carefully calibrated amounts, and women should never take multiple prenatal supplements simultaneously or add separate vitamin A pills without medical guidance. Lactating women face the highest requirements at 1,300 mcg RAE daily—nearly double standard female recommendations—to ensure adequate vitamin A transfers to breast milk, which typically contains 485 mcg/L.
Premature infants represent a particularly vulnerable group, born with inadequate hepatic vitamin A stores and immature gastrointestinal tracts compromising absorption. Approximately one-third of infants born between 22-28 weeks gestation develop bronchopulmonary dysplasia (BPD), a potentially fatal chronic lung disease. Research explores whether postnatal vitamin A administration reduces BPD incidence in very low birth weight infants. Individuals with inflammatory bowel disease (IBD), post-bariatric surgery patients, and those with pancreatic insufficiency or chronic liver disease experience compromised vitamin A status through malabsorption or impaired storage. These patients often require higher intake levels, regular monitoring of serum retinol, and potentially therapeutic supplementation under medical supervision. Vegans and vegetarians relying exclusively on provitamin A carotenoids must consume generous amounts of colorful vegetables daily, understanding that 12 mcg of dietary beta-carotene produces only 1 mcg retinol. Some individuals possess genetic variations reducing carotenoid conversion efficiency, potentially benefiting from small amounts of preformed vitamin A supplements in retinol form, though intake should not exceed 1,500 mcg RAE to avoid bone fracture risks identified in observational studies.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

